Johnson & Johnson Global Development’s Innovative Health is re-inventing the clinical trial experience by striving to develop and implement new approaches, novel technologies, and innovative ways of working to help meet the needs of our stakeholders: patients, trial sites/investigators and the healthcare industry at large.
Using a purposeful combination of processes, tools, skills, behaviors, and expertise, such as process optimization, design thinking and AI/ML enabled insight generation, the Innovation Health function within our Global Development organization – the backbone of drug development at J&J IM – equips the organization with insights on the dynamics and barriers our stakeholders face.
Some areas of focus include:
Patient voice in trial design
By including patients’ input during the early stages of clinical trial development, we are hoping to proactively address potential enrollment and retention challenges. We capture the “patient voice” through a variety of means, including social listening, patient interviews, surveys, and simulated trials.
Recruiting a representative patient population
We want to make certain that clinical research is accessible to all patients globally. We take care to follow the science and manage representative clinical trials.
Our Global Clinical Trial Finder is designed to help individuals easily access information on J&J-led clinical trials around the world that are currently accepting new participants. Those interested in enrolling can search for clinical trials by medical condition and geographic location.
Patient engagement and advocacy
We are spearheading global advocacy initiatives that elevate J&J through influencing policy, partnerships and publications, and championing health equity across the drug development ecosystem early and systematically. By embedding patient engagement and advocacy at the start of the drug development process, we can better address the needs of our patients.
Industry collaborations and leadership
True to our mission to transform clinical trials on a broad basis, we collaborate globally with leading healthcare organizations, technology partners and pharmaceutical companies. We also provide leadership to industry organizations that share in our vision for clinical trial innovation.